Drugmakers Say FDA’s FAR Guidance Contradicts Existing Regulations

International Pharmaceutical Regulatory Monitor
A A
FDA guidance on submitting field alert reports contradicts federal regulations on the time frame for when reports must be submitted, Perrigo and GlaxoSmithKline said in public comments.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00